Seeking Alpha

SQNM
Sequenom, Inc.

5/26/2012, 6:27 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
SQNM Market Currents more »
  • May 17 Sequenom (SQNM) says the recently announced provider network participation agreement with Coventry Health Care (CVH) has been terminated without cause by Coventry. The agreement was intended to provide members in the network with coverage for Sequenom CMM's MaterniT21 PLUS laboratory-developed test. SQNM -7.8% AH. [Healthcare, On the Move]
SQNM Instablog posts more »
  • Sequenom: T21 Prenatal Diagnostic Test Trend
    Tue, May 22 Marty Chilberg Comment!
  • Study Publication Featuring Sequenom, Inc. (SQNM) Center For Molecular Medicine’s MaterniT21 PLUS Featured In Prenatal Diagnosis
    Fri, May 18 MissionIR Comment!
  • Sequenom: Diagnostic Testing Lineup
    Wed, May 16 Marty Chilberg 5 Comments
  • Sequenom: Diagnostic Testing Drives Investment Thesis
    Tue, May 15 Marty Chilberg 6 Comments
  • Update: SQNM Faces Further Patent Litigation
    Wed, Jan 11 Disclosure Insight Comment!
Write a post on SQNM
SQNM StockTalks
SQNM vs. ETF Alternatives
Company Description

We are a diagnostic testing and genetics analysis company committed to providing products, services, diagnostic testing, applications and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine... More

Sector: Healthcare
Industry: Biotechnology
Country: United States